3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
2
Phase NA
1
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pain
6
Neoplasms
6
Cancer Pain
6
Pain, Intractable
2
Multiple Myeloma
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Leukemia, Biphenotypic, Acute
2
Leukemia
2
Waldenstrom Macroglobulinemia
1
Vesico-Ureteral Reflux
1
Ureteral Neoplasms
1
Thrombocythemia, Essential
1
Sigmoidal Tumour
1
Sezary Syndrome
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Pain, Postoperative
1
Nephrolithiasis
1
Neoplasms, Plasma Cell
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Mycosis Fungoides
1
Mucositis
1
Monoclonal Gammopathy of Undetermined Significance
1
Interventions
Fluorouracil
131
Leucovorin
127
Oxaliplatin
93
Bevacizumab
86
Irinotecan
74
Capecitabine
63
Cetuximab
47
Folfox protocol
32
Panitumumab
18
regorafenib
16
trifluridine tipiracil drug combination
15
Drug Therapy
14
Chemotherapy, Adjuvant
13
IFL protocol
10
Floxuridine
10
Radiotherapy
9
Tegafur
7
Neoadjuvant Therapy
7
Levoleucovorin
7
Laparoscopy
7
Aspirin
7
pembrolizumab
6
atezolizumab
6
Trifluridine
6
Celecoxib
6
XELOX
5
Mitomycin
5
Colonoscopy
5
tipiracil
4
sintilimab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Colorectal Neoplasms
×
Morphine
×
Clear all
NCT01318161
2021-02-16
EPICOL
Örebro University, Sweden
Phase 3
Terminated
221 enrolled